David L. Emerson

1.5k total citations
45 papers, 1.2k citations indexed

About

David L. Emerson is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, David L. Emerson has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in David L. Emerson's work include Vitamin D Research Studies (7 papers), Cancer therapeutics and mechanisms (7 papers) and Erythrocyte Function and Pathophysiology (5 papers). David L. Emerson is often cited by papers focused on Vitamin D Research Studies (7 papers), Cancer therapeutics and mechanisms (7 papers) and Erythrocyte Function and Pathophysiology (5 papers). David L. Emerson collaborates with scholars based in United States and United Kingdom. David L. Emerson's co-authors include Robert M. Galbraith, Mario Petrini, Pascal J. Goldschmidt‐Clermont, André E. Nel, Philippe Arnaud, Philippe Arnaud, William M. Lee, Michael J. Luzzio, Gordon D. McIntyre and R M Galbraith and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Hepatology.

In The Last Decade

David L. Emerson

44 papers receiving 1.2k citations

Peers

David L. Emerson
Wilberto Nieves‐Neira United States
Ryan Bender United States
Shigeru Tomoyasu Japan
Elena Tourkina United States
Benjamin Winograd Netherlands
Anthea Hardcastle United Kingdom
Thomas W. Davis United States
Connie L. Erickson‐Miller United States
Mary Ayres United States
Tingting Zhao China
Wilberto Nieves‐Neira United States
David L. Emerson
Citations per year, relative to David L. Emerson David L. Emerson (= 1×) peers Wilberto Nieves‐Neira

Countries citing papers authored by David L. Emerson

Since Specialization
Citations

This map shows the geographic impact of David L. Emerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Emerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Emerson more than expected).

Fields of papers citing papers by David L. Emerson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Emerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Emerson. The network helps show where David L. Emerson may publish in the future.

Co-authorship network of co-authors of David L. Emerson

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Emerson. A scholar is included among the top collaborators of David L. Emerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Emerson. David L. Emerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emerson, David L.. (2019). Mythology in Children's Animation. 38(1). 261.
2.
Fitzgerald, Daniel P., David L. Emerson, Yongzhen Qian, et al.. (2012). TPI-287, a New Taxane Family Member, Reduces the Brain Metastatic Colonization of Breast Cancer Cells. Molecular Cancer Therapeutics. 11(9). 1959–1967. 69 indexed citations
3.
4.
Tomkinson, Blake, et al.. (2003). OSI-211, a novel liposomal topoisomerase I inhibitor, is active in SCID mouse models of human AML and ALL. Leukemia Research. 27(11). 1039–1050. 31 indexed citations
5.
Desjardins, John, David L. Emerson, Blake Tomkinson, et al.. (2001). Biodistribution of NX211, liposomal lurtotecan, in tumor-bearing mice. Anti-Cancer Drugs. 12(3). 235–245. 15 indexed citations
6.
Emerson, David L., Raymond A. Bendele, Eric Brown, et al.. (2000). Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan.. PubMed. 6(7). 2903–12. 51 indexed citations
7.
Ignar, Diane M., John L. Andrews, William C. Clay, et al.. (1998). Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist. Clinical & Experimental Metastasis. 16(1). 9–20. 29 indexed citations
8.
Kost, Thomas A., Diane M. Ignar, William C. Clay, et al.. (1997). Production of a urokinase plasminogen activator-IgG fusion protein (uPA-IgG) in the baculovirus expression system. Gene. 190(1). 139–144. 8 indexed citations
9.
Conway, James G., Brian E. Marron, David L. Emerson, et al.. (1996). Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis. Clinical & Experimental Metastasis. 14(2). 115–124. 22 indexed citations
10.
Uehling, David, et al.. (1995). Synthesis, Topoisomerase I Inhibitory Activity, and in Vivo Evaluation of 11-Azacamptothecin Analogs. Journal of Medicinal Chemistry. 38(7). 1106–1118. 46 indexed citations
11.
Luzzio, Michael J., Jeffrey M. Besterman, David L. Emerson, et al.. (1995). Synthesis and Antitumor Activity of Novel Water Soluble Derivatives of Camptothecin as Specific Inhibitors of Topoisomerase I. Journal of Medicinal Chemistry. 38(3). 395–401. 122 indexed citations
12.
Lee, William M., et al.. (1987). Antibodies to polymerized human serum albumin in acute and chronic liver disease. Hepatology. 7(5). 906–912. 4 indexed citations
13.
14.
Emerson, David L., et al.. (1987). Qualitative and quantitative studies of Gc (vitamin D‐binding protein) in normal subjects and patients with periodontal disease. Journal of Periodontal Research. 22(4). 259–263. 13 indexed citations
15.
Katikaneni, Lakshmi, et al.. (1987). High Levels of Group-Specific Component (Vitamin-D-Binding Protein) in the Cerebrospinal Fluid of Infants Aged < 2 Months. Neonatology. 52(5). 250–255. 4 indexed citations
16.
Goldschmidt‐Clermont, Pascal J., et al.. (1985). Accurate quantitation of native Gc in serum and estimation of endogenous Gc : G-actin complexes by rocket immunoelectrophoresis. Clinica Chimica Acta. 148(3). 173–183. 29 indexed citations
17.
Gianazza, Elisabetta, David L. Emerson, Dale D. Dykes, & Philippe Arnaúd. (1984). The genetic variants of group-specific component (vitamin D-binding protein) possess different binding characteristics for immobilized Cibacron Blue 3-GA. Biochemical Journal. 218(3). 969–973. 9 indexed citations
18.
Emerson, David L., Philippe Arnaud, & Robert M. Galbraith. (1983). Evidence of Increased Gc: Actin Complexes in Pregnant Serum: A Possible Result of Trophoblast Embolism. American journal of reproductive immunology. 4(4). 185–189. 45 indexed citations
19.
Emerson, David L., Colette Chapuis‐Cellier, & Philippe Arnaúd. (1980). Horizontal two‐dimensional (iso‐dalt) electrophoresis: Use of agarose isoelectric focusing and SDS gel electrophoresis in an exponential gradient for characterization of plasma proteins. Electrophoresis. 1(3-4). 159–163. 3 indexed citations
20.
Emerson, David L.. (1973). OPTIMUM FIRM LOCATION AND THE THEORY OF PRODUCTION*. Journal of Regional Science. 13(3). 335–347. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilberto Nieves‐Neira Breakdown of academic impact, for papers by Ryan Bender Breakdown of academic impact, for papers by Shigeru Tomoyasu Breakdown of academic impact, for papers by Elena Tourkina Breakdown of academic impact, for papers by Benjamin Winograd Breakdown of academic impact, for papers by Anthea Hardcastle Breakdown of academic impact, for papers by Thomas W. Davis Breakdown of academic impact, for papers by Connie L. Erickson‐Miller Breakdown of academic impact, for papers by Mary Ayres Breakdown of academic impact, for papers by Tingting Zhao
Rankless by CCL
2026